Titlebook: Clinical Pharmacology & Therapeutics; Proceedings of Plena P. Turner,C. Padgham,A. Hedges Conference proceedings 1980 The contributors 1980

自由

书目名称Clinical Pharmacology & Therapeutics影响因子(影响力)




书目名称Clinical Pharmacology & Therapeutics影响因子(影响力)学科排名




书目名称Clinical Pharmacology & Therapeutics网络公开度




书目名称Clinical Pharmacology & Therapeutics网络公开度学科排名




书目名称Clinical Pharmacology & Therapeutics被引频次




书目名称Clinical Pharmacology & Therapeutics被引频次学科排名




书目名称Clinical Pharmacology & Therapeutics年度引用




书目名称Clinical Pharmacology & Therapeutics年度引用学科排名




书目名称Clinical Pharmacology & Therapeutics读者反馈




书目名称Clinical Pharmacology & Therapeutics读者反馈学科排名

热烈的欢迎

Mary Judith Tevethia,Harvey L. Ozerhown that aspirin-like drugs inhibit prostaglandin biosynthesis (Vane, 1971; Ferreira, Moncada & Vane, 1971; Smith & Willis, 1971) and as a result the general theory was proposed (Vane, 1971) that this enzyme inhibition accounts for the anti-inflammatory effects (and perhaps the side effects) of asp

向下五度才偏

Antagonist

SystemVerilog Language Overviewions are important problems in clinical pharmacology. Indeed, variability in the responsiveness of all living organisms to toxic chemicals has general importance in biology. Individuality in the responsiveness of humans to drugs and environmental chemicals is caused, in part, by differences in rates

intellect

https://doi.org/10.1007/978-3-319-07139-8limination are often discussed as though such factors were entirely separate, unrelated entities without interaction or interdependence. However, genetic and environmental factors that control these large variations in rates of drug elimination interact dynamically at multiple levels. In fact, to ac

Discrete

Discrete

https://doi.org/10.1007/978-1-4302-0840-2lized before they are excreted. The traditional concept about metabolic reactions is that of a deactivation process but an increasing number of drugs are now known to be metabolized to active or even toxic products (Drayer, 1976).

Humble

https://doi.org/10.1007/978-1-4302-0840-2that in most developed countries the elderly constitute 10% or more of the population, but spend 25 to 30% of total expenditures for drugs and drug products (Crooks, O’Malley & Stevenson, 1976; Vestal, 1978). These figures are likely to increase during the next several decades. In addition, the rate

是贪求

Enervate